Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Bioethics and Medical Ethics (5)
- Life Sciences (4)
- Medical Specialties (4)
- Geriatrics (2)
- Health Policy (2)
-
- Neurology (2)
- Neuroscience and Neurobiology (2)
- Public Affairs, Public Policy and Public Administration (2)
- Social and Behavioral Sciences (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Arts and Humanities (1)
- Biostatistics (1)
- Civil Rights and Discrimination (1)
- Communication (1)
- Diagnosis (1)
- Elder Law (1)
- Epidemiology (1)
- Health Communication (1)
- Health Services Research (1)
- History (1)
- History of Science, Technology, and Medicine (1)
- Law (1)
- Medical Sciences (1)
- Medicine and Health (1)
- Mental and Social Health (1)
- Neurosciences (1)
- Physical Sciences and Mathematics (1)
- Preventive Medicine (1)
- Psychiatric and Mental Health (1)
- Keyword
-
- Female (4)
- Humans (4)
- Male (4)
- Aged (3)
- Aged, 80 and over (2)
-
- Alzheimer Disease (2)
- Alzheimer's disease (2)
- Dementia (2)
- United States (2)
- *Patient Compliance (1)
- *Patient Participation (1)
- *Jurisprudence (1)
- *Politics (1)
- Adenosine Triphosphatases (1)
- Age Factors (1)
- Bioethics (1)
- Blotting, Western (1)
- Cell Cycle Proteins (1)
- Choice Behavior (1)
- Cognition Disorders (1)
- Competency (1)
- Diabetes Mellitus, Type 2 (1)
- Diagnosis (1)
- Drug Interactions (1)
- Drug development (1)
- Immunohistochemistry (1)
- Informatics/internet in medicine (1)
- Interviews as Topic (1)
- Long-term care (1)
- Medical education (1)
- File Type
Articles 1 - 10 of 10
Full-Text Articles in Medicine and Health Sciences
Trends In The Prevalence And Mortality Of Cognitive Impairment In The United States: Is There Evidence Of A Compression Of Cognitive Morbidity, Kenneth Langa, Eric Larson, Jason Karlawish, David Cutler, Mohammed Kabeto, Scott Kim, Allison Rosen
Trends In The Prevalence And Mortality Of Cognitive Impairment In The United States: Is There Evidence Of A Compression Of Cognitive Morbidity, Kenneth Langa, Eric Larson, Jason Karlawish, David Cutler, Mohammed Kabeto, Scott Kim, Allison Rosen
Jason Karlawish
BACKGROUND: Recent medical, demographic, and social trends might have had an important impact on the cognitive health of older adults. To assess the impact of these multiple trends, we compared the prevalence and 2-year mortality of cognitive impairment (CI) consistent with dementia in the United States in 1993 to 1995 and 2002 to 2004. METHODS: We used data from the Health and Retirement Study (HRS), a nationally representative population-based longitudinal survey of U.S. adults. Individuals aged 70 years or older from the 1993 (N = 7,406) and 2002 (N = 7,104) waves of the HRS were included. CI was determined …
The Search For A Coherent Language: The Science And Politics Of Drug Testing And Approval, Jason Karlawish
The Search For A Coherent Language: The Science And Politics Of Drug Testing And Approval, Jason Karlawish
Jason Karlawish
No abstract provided.
Novel Ubiquitin Neuropathology In Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations, Mark Forman, Ian Mackenzie, Nigel Cairns, Eric Swanson, Philip Boyer, David Drachman, Bharati Jhaveri, Jason Karlawish, Alan Pestronk, Thomas Smith, Pang-Hsien Tu, Giles Watts, William Markesbery, Charles Smith, Virginia Kimonis
Novel Ubiquitin Neuropathology In Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations, Mark Forman, Ian Mackenzie, Nigel Cairns, Eric Swanson, Philip Boyer, David Drachman, Bharati Jhaveri, Jason Karlawish, Alan Pestronk, Thomas Smith, Pang-Hsien Tu, Giles Watts, William Markesbery, Charles Smith, Virginia Kimonis
Jason Karlawish
Frontotemporal dementia (FTD) with inclusion body myopathy and Paget disease of bone (IBMPFD) is a rare, autosomal-dominant disorder caused by mutations in the valosin-containing protein (VCP) gene, a member of the AAA-ATPase gene superfamily. The neuropathology associated with sporadic FTD is heterogeneous and includes tauopathies and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U). However, there is limited information on the neuropathology in IBMPFD. We performed a detailed, systematic analysis of the neuropathologic changes in 8 patients with VCP mutations. A novel pattern of ubiquitin pathology was identified in IBMPFD that was distinct from sporadic and familial FTLD-U without VCP gene …
Older Adults’ Attitudes Toward Enrollment Of Noncompetent Subjects Participating In Alzheimer’S Research, Jason Karlawish, Jonathan Rubright, David Casarett, Mark Cary, Thomas Ten Have, Pamela Sankar
Older Adults’ Attitudes Toward Enrollment Of Noncompetent Subjects Participating In Alzheimer’S Research, Jason Karlawish, Jonathan Rubright, David Casarett, Mark Cary, Thomas Ten Have, Pamela Sankar
Jason Karlawish
OBJECTIVE: Research that seeks to enroll noncompetent patients with Alzheimer’s disease without presenting any potential benefit to participants is the source of substantial ethical controversy. The authors used hypothetical Alzheimer’s disease studies that included either a blood draw or a blood draw and lumbar puncture to explore older persons’ attitudes on this question. METHOD: Face-to-face interviews were conducted with 538 persons age 65 and older. Questions explored participants’ understanding of research concepts, their views on enrolling persons with Alzheimer’s disease in research, and their preferences regarding having a proxy decision maker, granting advance consent, and granting their proxy leeway to …
The Capacity To Vote Of Persons With Alzheimer's Disease, Paul Appelbaum, Richard Bonnie, Jason Karlawish
The Capacity To Vote Of Persons With Alzheimer's Disease, Paul Appelbaum, Richard Bonnie, Jason Karlawish
Jason Karlawish
OBJECTIVE: The right to vote can be abrogated when persons become incompetent to cast a ballot. This applies particularly to people with Alzheimer's disease, who at some point will lose capacity. A 2001 federal court decision offered the first clear criteria ("Doe voting capacity standard") for determining voting competence, focused on understanding the nature and effect of voting and on the ability to choose. This article explores how persons with Alzheimer's disease perform on these criteria. METHOD: The Doe standard was operationalized in a brief questionnaire, along with measures of appreciation and reasoning about voting choices. Performance was assessed in …
Beneath The Surface: Discovering The Unvoiced Concerns Of Older Adults With Type 2 Diabetes Mellitus, Jennifer Tjia, Jane Givens, Jason Karlawish, A. Okoli-Umeweni, Frances Barg
Beneath The Surface: Discovering The Unvoiced Concerns Of Older Adults With Type 2 Diabetes Mellitus, Jennifer Tjia, Jane Givens, Jason Karlawish, A. Okoli-Umeweni, Frances Barg
Jason Karlawish
Emerging clinical guidelines recommend shared decision making to individualize drug regimens for older adults with Type 2 diabetes mellitus. While the current health education campaign for diabetes in the United States recommends physician-initiated medication-related discussions about adherence and side effects, little emphasis is placed on soliciting patient concerns. This study's aim was to explore the concerns of older adults with diabetes about the complexity of their drug regimens and to determine whether they discussed medication-related concerns with their physician. Twenty-two patients with Type 2 diabetes age 65 years and older who used five or more medications were selected from an …
Desktop Medicine, Jason Karlawish
Addressing The Ethical, Legal, And Social Issues Raised By Voting By Persons With Dementia, Jason H. Karlawish, Richard J. Bonnie, Paul S. Appelbaum, Constantine Lyketsos, Bryan James, David Knopman, Christopher Patusky, Rosalie A. Kane, Pamela S. Karlan
Addressing The Ethical, Legal, And Social Issues Raised By Voting By Persons With Dementia, Jason H. Karlawish, Richard J. Bonnie, Paul S. Appelbaum, Constantine Lyketsos, Bryan James, David Knopman, Christopher Patusky, Rosalie A. Kane, Pamela S. Karlan
Jason Karlawish
This article addresses an emerging policy problem in the United States participation in the electoral process by citizens with dementia. At present, health care professionals, family caregivers, and long-term care staff lack adequate guidance to decide whether individuals with dementia should be precluded from or assisted in casting a ballot. Voting by persons with dementia raises a series of important questions about the autonomy of individuals with dementia, the integrity of the electoral process, and the prevention of fraud. Three subsidiary issues warrant special attention: development of a method to assess capacity to vote; identification of appropriate kinds of assistance …
The Capacity To Vote Of Persons With Alzheimer’S Disease, Paul S. Appelbaum, Richard S. Bonnie, Jason Karlawish
The Capacity To Vote Of Persons With Alzheimer’S Disease, Paul S. Appelbaum, Richard S. Bonnie, Jason Karlawish
Jason Karlawish
OBJECTIVE: The right to vote can be abrogated when persons become incompetent to cast a ballot. This applies particularly to people with Alzheimer’s disease, who at some point will lose capacity. A 2001 federal court decision offered the first clear criteria (“Doe voting capacity standard”) for determining voting competence, focused on understanding the nature and effect of voting and on the ability to choose. This article explores how persons with Alzheimer’s disease perform on these criteria. METHOD: The Doe standard was operationalized in a brief questionnaire, along with measures of appreciation and reasoning about voting choices. Performance was assessed in …
How Are We Going To Live With Alzheimer's Disease?, Jason Karlawish
How Are We Going To Live With Alzheimer's Disease?, Jason Karlawish
Jason Karlawish
No abstract provided.